Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 946Recruiting 324Terminated 269Unknown 234Active not recruiting 146Withdrawn 91Not yet recruiting 91Suspended 5No longer available 5Enrolling by invitation 3Available 1

Sponsor Class

OTHER 3INDUSTRY 3NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Plasma cell 3Classical hematology 1

Conditions

Breast Neoplasms 60Neoplasms 53Colorectal Neoplasms 32Prostatic Neoplasms 29Lung Neoplasms 22Stomach Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Carcinoma, Hepatocellular 16Uterine Cervical Neoplasms 14Anxiety Disorders 13Colonic Neoplasms 11Pancreatic Neoplasms 10Brain Neoplasms 10Lymphoma, Follicular 9Leukemia, Myeloid, Acute 8Esophageal Squamous Cell Carcinoma 8Barrett Esophagus 8Urinary Bladder Neoplasms 7Sarcoma 7Rectal Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Esophageal Neoplasms 7Epilepsy 7Disease 7Diabetes Mellitus 7Cholangiocarcinoma 7Cardiovascular Diseases 7Recurrence 6Pain 6

Interventions

carfilzomib 1Lenalidomide 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Multiple Myeloma × Clear all
NCT07410403 2026-02-13

AI

Zhongnan Hospital

Enrolling by invitation
10 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT05775224 2024-06-17

ASH Research Collaborative Data Hub

ASH Research Collaborative

Enrolling by invitation
100,000 enrolled
Classical hematologyPlasma cell

Anemia, Sickle Cell, Multiple Myeloma, Neoplasms, Plasma Cell

NCT03815279 2019-08-16

iStopMM

Landspitali University Hospital

Phase 2 Enrolling by invitation
80 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡